Celltrion Inc (068270)

Seoul
Currency in KRW
154,000
+500(+0.33%)
Closed·
068270 is included in our AI-picked strategies. See how they work
Fair Value
Day's Range
152,000154,000
52 wk Range
151,200211,000
Key Statistics
Edit
Bid/Ask
153,900.00 / 154,000.00
Prev. Close
153,500
Open
153,700
Day's Range
152,000-154,000
52 wk Range
151,200-211,000
Volume
416.64K
Average Volume (3m)
529.63K
1-Year Change
-20.21%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
068270 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
225,750
Upside
+46.59%
Members' Sentiments
Bearish
Bullish
ProTips
Currently not supported.
Show more

Celltrion Company Profile

Celltrion, Inc., together with its subsidiaries, develops and produces drugs based on proteins for the treatment of oncology in South Korea. The company markets biopharmaceuticals; generic pharmaceuticals; and covid-19 test kits. Its antibody biosimilar pipeline includes CT-P44 that is in phase 3 clinical trial for the treatment of multiple myeloma; CT-P51, which is in phase 3 clinical trial for the treatment of Melanoma, lung cancer; CT-P53, which is in phase 3 clinical trial for the treatment of multiple sclerosis; and CT-P55 that is in phase 3 clinical trial for the treatment of Psoriasis. Celltrion, Inc. was founded in 2002 and is headquartered in Incheon, South Korea.

Compare 068270 to Peers and Sector

Metrics to compare
068270
Peers
Sector
Relationship
P/E Ratio
77.7x16.5x−0.5x
PEG Ratio
−1.710.030.00
Price/Book
1.9x1.6x2.6x
Price / LTM Sales
9.2x4.2x2.9x
Upside (Analyst Target)
49.4%23.8%49.4%
Fair Value Upside
Unlock13.3%8.2%Unlock

Analyst Ratings

18 Buy
1 Hold
1 Sell
Ratings:
20 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 225,750
(+46.59% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1,950.47%
Dividend Yield
0.49%
Industry Median 0.24%
Annualised payout
750.00
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
May 09, 2025
EPS / Forecast
481.37 / 726.59
Revenue / Forecast
841.90B / 989.14B
EPS Revisions
Last 90 days

FAQ

What Is the Celltrion (068270) Stock Price Today?

The Celltrion stock price today is 154,000.00.

What Stock Exchange Does Celltrion Trade On?

Celltrion is listed and trades on the Seoul Stock Exchange stock exchange.

What Is the Stock Symbol for Celltrion?

The stock symbol for Celltrion is "068270."

Does Celltrion Pay Dividends? What’s The Current Dividend Yield?

The Celltrion dividend yield is 0.49%.

What Is the Celltrion Market Cap?

As of today, Celltrion market cap is 32.83T.

What Is Celltrion's Earnings Per Share (TTM)?

The Celltrion EPS (TTM) is 1,950.47.

When Is the Next Celltrion Earnings Date?

Celltrion will release its next earnings report on 07 Aug 2025.

From a Technical Analysis Perspective, Is 068270 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.